ROBERT DELAUNE M.D. NPI 1497723514

NPI Details

Robert Delaune, M.D. is a hematology and oncology internal medicine in Maplewood, MN with 35 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Robert Delaune, M.D. NPI is 1497723514. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:1991

The provider's business location address is:

1580 BEAM AVE
MAPLEWOOD, MN
ZIP 55109-127
Phone: (651) 779-7978
Fax: (651) 779-7656

The NPI 1497723514 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Unclassified drugs (HCPCS:J3490)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ct scan of chest without contrast (HCPCS:71250)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood creatinine level (HCPCS:82565)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Urinalysis, manual test (HCPCS:81002)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 3/14/2006 and was last updated on 10/13/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.